Author + information
- Parshva Patela,b,
- Subir Bhatiaa,b,
- Shilpkumar Aroraa,b,
- Kanishk Agnihotria,b and
- Abhishek Deshmukha,b
Background: The prevalence and outcomes in patients presenting with acute coronary syndrome with pre-existing cancer has been under-represented in major clinical trials. We sought to assess the temporal trends in the prevalence of Non ST elevation Myocardial Infarction (NSTEMI) with the most prevalent cancer types.
Methods: We queried largest publicly available HCUP's inpatient database- Nationwide Inpatient Sample (NIS) between 1998 to 2013 using ICD9 code (410.7) for NSTEMI. Only admission with age 18 years and older were included. Cost of hospitalization was adjusted for cost to charge ratio files. Appropriate ICD-9-CM codes were used to solid tumor cancer sub-types (prostate, breast, lung, pancreas, liver, rectum, colon, esophagus).
Results: Among 1,939,818 (weighted n=9,266,020) patients hospitalized for NSTEMI, the mean age was 70.6±0.01 years and 55% of patients were female. Average Length of Stay was 6.66±0.01 days with cost of hospitalization of $20538.29±20.4. In-hospital mortality of patients presenting with NSTEMI was significantly higher if they had cancer compared to those without cancer (Table 1). NSTEMI incidence significantly increased in patients with cancer during the study period (Figure 1).
Conclusions: Patients presenting with a NSTEMI have significantly higher in-hospital mortality if they have a solid tumor cancer compared to those without. The incidence of NSTEMI in solid tumor cancer patients was found to increase during the study period.
Moderated Poster Contributions
Acute and Stable Ischemic Heart Disease Moderated Poster Theater, Poster Hall, Hall C
Sunday, March 19, 2017, 9:45 a.m.-9:55 a.m.
Session Title: CAD in Unique Patient Populations
Abstract Category: 2. Acute and Stable Ischemic Heart Disease: Clinical
Presentation Number: 1309M-03
- 2017 American College of Cardiology Foundation